candesartan has been researched along with minocycline in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Fagan, SC; Fouda, AY; Ishrat, T; Patel, A; Pillai, B; Soliman, S | 1 |
1 review(s) available for candesartan and minocycline
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for candesartan and minocycline
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Sequential Therapy with Minocycline and Candesartan Improves Long-Term Recovery After Experimental Stroke.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Brain Infarction; Cell Movement; Cell Proliferation; Cerebrovascular Trauma; Disease Models, Animal; Endothelium, Vascular; Epithelial Cells; Humans; Hydro-Lyases; Infarction, Middle Cerebral Artery; Male; Matrix Metalloproteinases; Minocycline; Motor Activity; Muscle Strength; Psychomotor Performance; Rats; Rats, Wistar; Recovery of Function; Tetrazoles; Time Factors; Vascular Endothelial Growth Factor A | 2015 |